Genetic variation of GPLD1 associates with serum GPI-PLD levels: a preliminary study.

[1]  D. W. Moss,et al.  Inositol-specific phospholipase D activity in health and disease. , 1994, Clinical science.

[2]  A. Manatunga,et al.  Longitudinal assessment of blood pressures in black and white children. , 1993, Hypertension.

[3]  P. Bütikofer,et al.  Subcellular distribution of glycosylphosphatidylinositol-specific phospholipase D in rat liver. , 1996, The Biochemical journal.

[4]  M. Hoener,et al.  Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins. , 1992, European journal of biochemistry.

[5]  N. Chalasani,et al.  Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[7]  M. G. Low,et al.  Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance. , 2010, Metabolism: clinical and experimental.

[8]  Christian Gieger,et al.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma , 2011, Nature Genetics.

[9]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[10]  S. Hurel,et al.  Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats. , 2002, Molecular genetics and metabolism.

[11]  J. Gruen,et al.  Peaks of linkage are localized by a BAC/PAC contig of the 6p reading disability locus. , 2001, Genomics.

[12]  L. Olson,et al.  Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization , 1998, Mammalian Genome.

[13]  D. D’Alessio,et al.  Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women. , 2008, Metabolism: clinical and experimental.

[14]  J. Schofield,et al.  Structure and expression of the human glycosylphosphatidylinositol phospholipase D1 (GPLD1) gene. , 2000, Biochimica et Biophysica Acta.

[15]  G. Maguire,et al.  Glycosyl Phosphatidyl Inositol Phospholipase D Activity in Human Serum , 1995, Annals of clinical biochemistry.

[16]  N. Fineberg,et al.  Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D. , 2004, Metabolism: clinical and experimental.

[17]  V. Nussenzweig,et al.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes , 1984, The Journal of experimental medicine.

[18]  S. Tishkoff,et al.  African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. , 2008, Annual review of genomics and human genetics.

[19]  M. Deeg,et al.  Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D. , 2007, Translational research : the journal of laboratory and clinical medicine.

[20]  H. Brewer,et al.  Characterization of high density lipoprotein-bound and soluble RT6 released following administration of anti-RT6.1 monoclonal antibody. , 1998, Journal of immunology.

[21]  Scott M. Williams,et al.  The Genetic Structure and History of Africans and African Americans , 2009, Science.

[22]  M. Cheung,et al.  GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex. , 2001, Journal of lipid research.

[23]  Luigi Ferrucci,et al.  Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. , 2008, American journal of human genetics.

[24]  M. Deeg,et al.  Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. , 2006, American journal of physiology. Endocrinology and metabolism.

[25]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.